Pylarify BPA
Ended Awarded Last action
- Contract number
- 36C25222A0035
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 2 $1,400,749 obligated
Award facts
- Opportunity
-
- 36C25222Q0639 Solicitation number
- Combined order value
-
- $2,075,355 Current, with exercised options
- $2,782,355 Potential, with all options
- Last date to order 100% complete
- Maximum order
- $200,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Blanket Purchase Agreement to Progenics Pharmaceuticals Inc. for PYLARIFY products and services. The single award BPA, valued at over $1.3 million, was issued on July 15, 2022 against the Pharmaceuticals and Drugs Federal Supply Schedule master contract for the period of July 15, 2022 through June 14, 2024. Performance will take place in New York, New York.
The BPA calls authorize the delivery of PYLARIFY, a radiopharmaceutical used in positron emission tomography imaging to aid in the detection and localization of prostate cancer. Firm fixed pricing is established for two BPA call periods, from July 15, 2022 to July 14, 2023 valued at $1,381,605.44, and from July 15, 2023 to June 14, 2024 valued at $1,324,175.04. As the prime contractor, Progenics Pharmaceuticals will provide the contracted products and services to support diagnostic imaging services for veterans treated by the VA network, advancing their efforts to accurately diagnose and manage prostate cancer.
No subcontractors or set-asides were specified. The BPA was competitively awarded off the GSA Pharmaceuticals and Drugs schedule in accordance with federal procurement regulations to meet the network's projected demand for prostate cancer radiopharmaceuticals.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pylarify BPA | Veterans Integrated Service Network 12 (VHA) | $726,144 | |
| Pylarify BPA | Veterans Integrated Service Network 12 (VHA) | $674,605 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C25222A0035?
36C25222A0035 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 15, 2022.
How much is contract 36C25222A0035 worth?
Orders under 36C25222A0035 have obligated $1,400,749. Their combined current value, with exercised options, is $2,075,355. Their combined potential value, with all options, is $2,782,355. A single order can be worth up to $200,000.
How many orders have been placed under contract 36C25222A0035?
2 orders have been placed under 36C25222A0035, the latest on July 15, 2023.
Who can order from contract 36C25222A0035?
36C25222A0035 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36C25222A0035 under another contract?
Yes. 36C25222A0035 is a blanket purchase agreement under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25222A0035 competed?
The extent of competition for 36C25222A0035 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV